New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours but experts fear NHS can't afford them
Related Articles
-
The extraordinary promise of personalised cancer vaccines – podcast
Glioblastomas are an extremely aggressive type of brain tumour, which is why the news this week of a vaccine that has shown promise in fighting them is so exciting. And this comes right off the back of the announcement of another trial of the world’s first personalised mRNA vaccine for melanoma, a kind of skin cancer. Ian Sample talks to Prof Alan Melcher of the Institute of Cancer Research about how these vaccines work and whether they could one day be used to target cancer before it is even...
-
‘Real hope’ for cancer cure as personal mRNA vaccine for melanoma trialled
Excitement among patients and researchers as custom-built jabs enter phase 3 trialDoctors have begun trialling in hundreds of patients the world’s first personalised mRNA cancer vaccine for melanoma, as experts hailed its “gamechanging” potential to permanently cure cancer.Melanoma affects about 132,000 people a year globally and is the biggest skin cancer killer. Currently, surgery is the main treatment although radiotherapy, medicines and chemotherapy are also sometimes used. Continue reading
-
I Went to the Hospital With Flu-Like Symptoms 27 Weeks Pregnant & Found Out I Had Cancer
Mom Jaclyn Lin, was diagnosed with stage 4 pancreatic cancer during pregnancy and wants all women to learn to advocate for their health.